A phase III, open-label, randomized comparison of AS1413 (amonafide L-malate) plus cytarabine with daunorubicin plus cytarabine in secondary acute myeloid leukemia (ACCEDE) Meeting Abstract
| Authors: | Stone, R. M.; Allen, S. L.; Pigneux, A.; Stuart, R. K.; Wetzler, M.; Rizzieri, D.; Erba, H. P.; Damon, L. E.; Jang, J. H.; Tallman, M. S.; Warzocha, K.; Masszi, T.; Sekeres, M. A.; Miklos, E.; Horst, H.; Selleslag, D. L. D.; Solomon, S. R.; Venugopal, P.; Lundberg, A. S.; Powell, B. L. |
| Abstract Title: | A phase III, open-label, randomized comparison of AS1413 (amonafide L-malate) plus cytarabine with daunorubicin plus cytarabine in secondary acute myeloid leukemia (ACCEDE) |
| Meeting Title: | 47th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 29 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2011 Jun 3-7 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2011-05-20 |
| Language: | English |
| ACCESSION: | WOS:000208880302027 |
| DOI: | 10.1200/jco.2011.29.15_suppl.6520 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 6520 -- Source: Wos |
